Đang chuẩn bị liên kết để tải về tài liệu:
Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The differentiation between pancreatic head cancer (PHC) and distal cholangiocarcinoma (DCC) can be challenging because of their anatomical and histopathological similarity. This is an important problem, because the distinction has important implications for the treatment of these malignancies. | Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis

TÀI LIỆU LIÊN QUAN

Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling

Evaluation of protein biomarkers of prostate cancer aggressiveness

A novel Markov Blanket-based repeated-fishing strategy for capturing phenotype-related biomarkers in big omics data

ONCOGENOMICS AND CANCER PROTEOMICS – NOVEL APPROACHES IN BIOMARKERS DISCOVERY AND THERAPEUTIC TARGETS IN CANCER

Identifcation of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA‑Seq

Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma

Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer

Novel nomogram for predicting the progression of osteoarthritis based on 3DMRI bone shape: Data from the FNIH OA biomarkers consortium

Discovery of novel biomarkers and phenotypes by semantic technologies

Báo cáo y học: "Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsi"